IDEXX Laboratories, Inc. (NASDAQ:IDXX) insider Giovani Twigge sold 2,000 shares of the business’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $156.07, for a total value of $312,140.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of IDEXX Laboratories, Inc. (IDXX) opened at $159.99 on Thursday. The stock has a market capitalization of $13,935.81, a PE ratio of 53.80, a PEG ratio of 2.42 and a beta of 0.42. IDEXX Laboratories, Inc. has a 52 week low of $113.92 and a 52 week high of $173.01. The company has a debt-to-equity ratio of -12.48, a quick ratio of 0.77 and a current ratio of 0.95.

IDEXX Laboratories (NASDAQ:IDXX) last announced its earnings results on Tuesday, October 31st. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.74 by $0.05. IDEXX Laboratories had a negative return on equity of 336.64% and a net margin of 14.55%. The firm had revenue of $492.00 million during the quarter, compared to the consensus estimate of $492.94 million. During the same quarter in the prior year, the company earned $0.62 EPS. The firm’s revenue for the quarter was up 9.7% compared to the same quarter last year. research analysts expect that IDEXX Laboratories, Inc. will post 3.24 earnings per share for the current year.

A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in IDEXX Laboratories by 4.0% during the 2nd quarter. Vanguard Group Inc. now owns 9,264,579 shares of the company’s stock valued at $1,495,488,000 after purchasing an additional 354,024 shares during the period. BlackRock Inc. boosted its stake in IDEXX Laboratories by 10.5% during the 2nd quarter. BlackRock Inc. now owns 7,100,374 shares of the company’s stock valued at $1,146,142,000 after purchasing an additional 673,347 shares during the period. Koch Industries Inc. boosted its stake in IDEXX Laboratories by 44,533.1% during the 2nd quarter. Koch Industries Inc. now owns 1,399,248 shares of the company’s stock valued at $1,391,000 after purchasing an additional 1,396,113 shares during the period. Renaissance Technologies LLC boosted its stake in IDEXX Laboratories by 38.6% during the 2nd quarter. Renaissance Technologies LLC now owns 1,351,900 shares of the company’s stock valued at $218,224,000 after purchasing an additional 376,300 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its stake in IDEXX Laboratories by 42.8% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,310,660 shares of the company’s stock valued at $211,567,000 after purchasing an additional 392,790 shares during the period. Hedge funds and other institutional investors own 86.80% of the company’s stock.

Several research firms have recently issued reports on IDXX. Canaccord Genuity reiterated a “buy” rating and set a $180.00 price target on shares of IDEXX Laboratories in a research note on Friday, October 6th. Bank of America upgraded IDEXX Laboratories from a “neutral” rating to a “buy” rating and set a $175.00 price target for the company in a research note on Wednesday, August 23rd. Zacks Investment Research upgraded IDEXX Laboratories from a “hold” rating to a “buy” rating and set a $184.00 price target for the company in a research note on Tuesday, October 24th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $185.00 price target on shares of IDEXX Laboratories in a research note on Tuesday, October 24th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company’s stock. IDEXX Laboratories presently has a consensus rating of “Hold” and a consensus target price of $173.67.

TRADEMARK VIOLATION NOTICE: This article was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2017/12/07/insider-selling-idexx-laboratories-inc-idxx-insider-sells-312140-00-in-stock.html.

About IDEXX Laboratories

IDEXX Laboratories, Inc develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

Insider Buying and Selling by Quarter for IDEXX Laboratories (NASDAQ:IDXX)

Receive News & Ratings for IDEXX Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.